Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Grant or award Director acquired 99,483 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Director acquired 56,818 shares (grant or award)
  4. 4 Grant or award Director acquired 56,818 shares (grant or award)
  5. 4 Grant or award Director acquired 68,182 shares (grant or award)
  6. 4 Grant or award Director acquired 56,818 shares (grant or award)
  7. 4 Grant or award Vice President of Operations acquired 185,748 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award CEO acquired 65,376 shares (grant or award)
  10. 4 Grant or award Medical Director acquired 20,067 shares (grant or award)
  11. 4 Grant or award CFO acquired 18,015 shares (grant or award)
  12. 4 Grant or award Medical Director acquired 43,962 shares (grant or award)
  13. 4 Grant or award CEO acquired 154,527 shares (grant or award)
  14. 4 Grant or award CFO acquired 37,791 shares (grant or award)
  15. 4 Grant or award CEO acquired 192,870 shares (grant or award)
  16. 4 Grant or award Medical Director acquired 54,015 shares (grant or award)
  17. 4 Grant or award CFO acquired 47,118 shares (grant or award)
  18. 4 Grant or award CEO acquired 405,909 shares (grant or award)
  19. 4 Grant or award Medical Director acquired 112,542 shares (grant or award)
  20. 4 Grant or award Director acquired 508,528 shares (grant or award)

Page 24 of 31 · 616 filings